Table of Contents

company-logo

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

DSM-Firmenich Dividend Announcement

• DSM-Firmenich announced a annually dividend of €2.50 per ordinary share which will be made payable on 2024-05-16. Ex dividend date: 2024-05-09
• DSM-Firmenich annual dividend for 2024 was €2.50
• DSM-Firmenich annual dividend for 2023 was €1.60
• DSM-Firmenich's trailing twelve-month (TTM) dividend yield is 2.46%
• DSM-Firmenich's payout ratio for the trailing twelve months (TTM) is -426.58%

DSM-Firmenich Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-05-09€2.50annually2024-05-16
2023-07-03€1.60annually2023-07-06

DSM-Firmenich Dividend per year

DSM-Firmenich Dividend Yield

DSM-Firmenich current trailing twelve-month (TTM) dividend yield is 2.46%. Interested in purchasing DSM-Firmenich stock? Use our calculator to estimate your expected dividend yield:

DSM-Firmenich Financial Ratios

P/E ratio-141.50
PEG ratio-4.93
P/B ratio1.22
ROE-0.84%
Payout ratio-426.58%
Current ratio1.72
Quick ratio0.97
Cash Ratio0.21

DSM-Firmenich Dividend FAQ

Does DSM-Firmenich stock pay dividends?
DSM-Firmenich does not currently pay dividends to its shareholders.
Has DSM-Firmenich ever paid a dividend?
No, DSM-Firmenich has no a history of paying dividends to its shareholders. DSM-Firmenich is not known for its dividend payments.
Why doesn't DSM-Firmenich pay dividends?
There are several potential reasons why DSM-Firmenich would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will DSM-Firmenich ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While DSM-Firmenich has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is DSM-Firmenich a dividend aristocrat?
DSM-Firmenich is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is DSM-Firmenich a dividend king?
DSM-Firmenich is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is DSM-Firmenich a dividend stock?
No, DSM-Firmenich is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy DSM-Firmenich stocks?
To buy DSM-Firmenich you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy DSM-Firmenich stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.